A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Bristol-Myers Squibb
DEKA Biosciences
Eli Lilly and Company
City of Hope Medical Center
Rutgers, The State University of New Jersey